Names that match “St Mar Enterprises, Inc”
1,814 documents found
1533, 1537 (S.D.N.Y.1983) (holding corre
document IMAGES-004-HOUSE_OVERSIGHT_017885.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
… (holding corre-
spondent banking relationships insufficient
to create general personal jurisdiction).
NCB offers its customers the opportunity
to open accounts directly with United
States-based securities broker-dealers, but
NCB does not act as a broker-dealer for
securities sol...
Third, the report highlights how powerful bipartisan constituencies have emerged in the past to
document IMAGES-006-HOUSE_OVERSIGHT_020827.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
Third, the report highlights how powerful bipartisan constituencies have emerged in the past to
tackle great issues for the betterment of our nation, including tax reform, civil liberties,
healthcare, education and national defense. Just as presidents of both parties rose to the...
Bellingham, Washington
document IMAGES-008-HOUSE_OVERSIGHT_024794.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
…
and California.
O sclabs
SC Laboratories
Santa Cruz, California
www.sclabs.com
SC Laboratories is a cannabis lab-testing com-
pany. The company tests cannabis and cannabis-
based products for potency, pesticides and
microbiology, adhering to FDA and_ other
guidelines in its...
High-Level Thoughts on
document IMAGES-006-HOUSE_OVERSIGHT_020854.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
High-Level Thoughts on
Income Statement/Balance Sheet
KP
CC —— USA Inc. | High Level Thoughts 25
How Would You Feel if...
...your Cash Flow was NEGATIVE for
each of the past 9 years...
... your Net Worth* has been
NEGATIVE for as long as you can
remember...
... t would take...
Paul J. Set Theory and the Continuum Hypothesis. Dover Publications Inc
document Cohen House Oversight Committee — Epstein Estate Records (Nov 2025)
Paul J. Set Theory and the Continuum Hypothesis. Dover Publications Inc.
USA Inc.’s financial liabilities -- whether they are actual
document e Unless they are reduced House Oversight Committee — Epstein Estate Records (Nov 2025)
USA Inc.’s financial liabilities -- whether they are actual
and/or was involved in Novamente LLC and Webmind Inc
document involved with the OpenCog project House Oversight Committee — Epstein Estate Records (Nov 2025)
and/or was involved in Novamente LLC and Webmind Inc.
Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%
document Acadia Phamaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%
Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%
document Ambit Biosciences House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%
Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%
document Audax Health Solutions House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%
Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%
document Chimerix House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%
Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%
document Epizyme House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%
Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM
document Glumetrics House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM
Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6%
document Intercept Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6%
Inc. Therapeutics 2011 2.4 02 - 0.2 0.07 0.07 -91.6%
document Kalidex Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2011 2.4 02 - 0.2 0.07 0.07 -91.6%